Logo-apb
Original Research

1. Nucleostemin depletion induces post-G1 arrest apoptosis in chronic myelogenous leukemia K562 cells
Negin Gogani, Marveh Rahmati, Nosratollah Zarghami, Iraj Asvadi-Kermani, Mohammad Ali Hoseinpour-Feyzi, Mohammad Amin Moosavi*
Adv Pharm Bull. 2014;4(1): 55-60. doi: 10.5681/apb.2014.009
PMCID: PMC3885370     PMID: 24409410     Scopus ID: 84892465978    
Article
PDF
XML
Cited By:
15
7
Original Research

2. Clofarabine Has Apoptotic Effect on T47D Breast Cancer Cell Line via P53R2 Gene Expression
Mohammad Rahmati-Yamchi*, Nosratollah Zarghami, Hojjatollah Nozad Charoudeh, Yasin Ahmadi, Behzad Baradaran, Mohammad Khalaj-Kondori, Morteza Milani, Abolfazl Akbarzadeh, Maghsud Shaker, Mohammad Pourhassan-Moghaddam
Adv Pharm Bull. 2015;5(4): 471-476. doi: 10.15171/apb.2015.064
PMCID: PMC4729341     PMID: 26819918     Scopus ID: 84949676122    
Article
PDF
XML
Cited By:
4
0
4
Original Research

3. Chaperone-Assisted Soluble Expression of a Humanized Anti-EGFR ScFv Antibody in E. Coli
Kamal Veisi, Safar Farajnia*, Nosratollah Zarghami, Hamid Reza Khoram Khorshid, Nasser Samadi, Shiva Ahdi Khosroshahi, Hossein Zarei Jaliani
Adv Pharm Bull. 2015;5(5): 621-627. doi: 10.15171/apb.2015.084
PMCID: PMC4708032     PMID: 26793607     Scopus ID: 84954104894    
Article
PDF
XML
Cited By:
11
7
11
Original Research

4. Generation of New M2e-HA2 Fusion Chimeric Peptide to Development of a Recombinant Fusion Protein Vaccine
Ali Ameghi, Behzad Baradaran, Khosrow Aghaiypour*, Abolfazl Barzegar, Yones Pilehvar-Soltanahmadi, Masood Moghadampour, Morteza Taghizadeh, Nosratollah Zarghami*
Adv Pharm Bull. 2015;5(5): 673-681. doi: 10.15171/apb.2015.092
PMCID: PMC4708040     PMID: 26793615     Scopus ID: 84954120716    
Article
PDF
XML
Cited By:
7
3
7
Research Article

5. Cloning and Expression of Recombinant Human Endostatin in Periplasm of Escherichia coli Expression System
Abbas Mohajeri, Yones Pilehvar-Soltanahmadi, Mohammad Pourhassan-Moghaddam, Jalal Abdolalizadeh, Pouran Karimi, Nosratollah Zarghami*
Adv Pharm Bull. 2016;6(2): 187-194. doi: 10.15171/apb.2016.026
PMCID: PMC4961976     PMID: 27478780     Scopus ID: 84980383507    
Article
PDF
XML
Cited By:
8
4
9
Review Article

6. The Challenges of Recombinant Endostatin in Clinical Application: Focus on the Different Expression Systems and Molecular Bioengineering
Abbas Mohajeri, Sarvin Sanaei, Farhad Kiafar, Amir Fattahi, Majid Khalili, Nosratollah Zarghami*
Adv Pharm Bull. 2017;7(1): 21-34. doi: 10.15171/apb.2017.004
PMCID: PMC5426730     PMID: 28507934     Scopus ID: 85017542839    
Article
PDF
XML
Cited By:
14
10
13
Research Article

7. Multiplex Genome Editing in Chinese Hamster Ovary Cell Line Using All-in-One and HITI CRISPR Technology
Fatemeh Safari ORCID, Safar Farajnia* ORCID, Younes Ghasemi, Nosratollah Zarghami, Mazyar Barekati Mowahed
Adv Pharm Bull. 2021;11(2): 343-350. doi: 10.34172/apb.2021.032
PMCID: PMC8046387     PMID: 33880357     Scopus ID: 85103175015    
Article
PDF
Full Text
XML
Cited By:
1
3
3
Research Article

8. Assessment of E. coli Expression System for Overexpression of Active Recombinant Ocriplasmin
Roghayyeh Baghban ORCID, Safar Farajnia* ORCID, Younes Ghasemi, Mojtaba Mortazavi, Naser Samadi, Nosratollah Zarghami
Adv Pharm Bull. 2021;11(3): 564-569. doi: 10.34172/apb.2021.065
PMCID: PMC8421613     PMID: 34513632     Scopus ID: 85108914278    
Article
PDF
Full Text
XML
Cited By:
0
0
0

Research Article

9. Co-Administration of Vadimezan and Recombinant Coagulase-NGR Inhibits Growth of Melanoma Tumor in Mice
Amir Daei Farshchi Adli, Rana Jahanban-Esfahlan, Khaled Seidi, Davoud Farajzadeh, Ramezan Behzadi, Nosratollah Zarghami* ORCID
Adv Pharm Bull. 2021;11(2): 385-392. doi: 10.34172/apb.2021.037
PMCID: PMC8046391     PMID: 33880362     Scopus ID: 85103213880    
Article
PDF
Full Text
XML
Cited By:
2
4
3
Review Article

10. Isothermal Amplification of Nucleic Acids Coupled with Nanotechnology and Microfluidic Platforms for Detecting Antimicrobial Drug Resistance and Beyond
Seyedeh Zahra Alamolhoda ORCID, Nosratollah Zarghami, Houman Kahroba, Ahmad Mehdipour, Mohammad Pourhassan-Moghaddam, Rana Jahanban-Esfahlan* ORCID, Morteza Milani* ORCID
Adv Pharm Bull. 2022;12(1): 58-76. doi: 10.34172/apb.2022.004
PMCID: PMC9012923     PMID: 35517891     Scopus ID: 85113993879    
Article
PDF
Full Text
XML
Cited By:
2
2
2
Research Article

11. The Combined Thermoresponsive Cell-Imprinted Substrate, Induced Differentiation, and “KLC Sheet” Formation
Neda Keyhanvar* ORCID, Nosratollah Zarghami, Alexander Seifalian, Peyman Keyhanvar, Rana Sarvari, Roya Salehi, Reza Rahbarghazi, Mohammadreza Ranjkesh, Molood Akbarzadeh, Mahdi Mahdipour, Mohammad Nouri* ORCID
Adv Pharm Bull. 2022;12(2): 356-365. doi: 10.34172/apb.2022.034
PMCID: PMC9106954     PMID: 35620328     Scopus ID: 85128168017    
Article
PDF
Full Text
XML
Cited By:
2
1
2

Research Article

12. In Vitro Efficacy of Curcumin-Loaded Amine-Functionalized Mesoporous Silica Nanoparticles against MCF-7 Breast Cancer Cells
Zahra Mohebian, Mirzaagha Babazadeh, Nosratollah Zarghami* ORCID
Adv Pharm Bull. 2023;13(2): 317-327. doi: 10.34172/apb.2023.035
PMCID: PMC10278223     PMID: 37342377    
Article
PDF
Full Text
XML
Cited By:
1
1

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by